Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Haddadin Yezan Munther
Director at Outlook Therapeutics. Filing since 22 Sep 2020.
CIK 0001718004
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
2 Jun 2026
Director
Bought
29,000
$24.15K
78.0%
OTLK
Outlook Therapeutics, Inc.
26 May 2026
Director
Bought
34,000
$14.96K
×11
OTLK
Outlook Therapeutics, Inc.
28 Mar 2024
Director
Bought
1,882
$22.24K
59.4%
OTLK
Outlook Therapeutics, Inc.
7 Oct 2022
Director
Bought
3,600
$4.57K
6.0%
OTLK
Outlook Therapeutics, Inc.
6 Oct 2022
Director
Bought
29,743
$38.37K
99.1%
OTLK
Outlook Therapeutics, Inc.
2 Dec 2021
Director
Bought
10,000
$13.90K
50.0%
OTLK
Outlook Therapeutics, Inc.
19 Apr 2021
Director
Bought
10,000
$18.20K
100%
OTLK
Outlook Therapeutics, Inc.
22 Sep 2020
Director
Bought
10,000
$7.25K
opened
8 decisions on file.
